Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | glutathione reductase | 0.0061 | 0.1017 | 0.2803 |
Plasmodium vivax | glutathione reductase, putative | 0.0177 | 0.3077 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0061 | 0.1017 | 0.2803 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0061 | 0.1017 | 0.1057 |
Echinococcus multilocularis | citrate lyase subunit beta protein | 0.0051 | 0.0832 | 0.1044 |
Treponema pallidum | NADH oxidase | 0.0061 | 0.1017 | 1 |
Brugia malayi | Thioredoxin reductase | 0.0177 | 0.3077 | 0.8962 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0061 | 0.1017 | 0.1057 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0061 | 0.1017 | 0.1057 |
Plasmodium falciparum | glutathione reductase | 0.0177 | 0.3077 | 1 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0449 | 0.792 | 1 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0424 | 0.7488 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0196 | 0.3424 | 0.4532 |
Trichomonas vaginalis | apoptosis inducing factor, putative | 0.0016 | 0.0214 | 0.0502 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.002 | 0.0273 | 0.0292 |
Schistosoma mansoni | sulfide quinone reductase | 0.0016 | 0.0214 | 0.0214 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0442 | 0.7806 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0061 | 0.1017 | 0.2803 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0177 | 0.3077 | 0.3772 |
Loa Loa (eye worm) | pyridine nucleotide-disufhide oxidoreductase | 0.0016 | 0.0214 | 0.0377 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0016 | 0.0214 | 0.0213 |
Mycobacterium ulcerans | hypothetical protein | 0.0051 | 0.0832 | 0.7694 |
Brugia malayi | glutamate synthase | 0.0016 | 0.0214 | 0.0383 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0273 | 0.0206 |
Trichomonas vaginalis | Citrate lyase beta chain, putative | 0.0051 | 0.0832 | 0.233 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0061 | 0.1017 | 0.1057 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.002 | 0.0273 | 0.056 |
Schistosoma mansoni | glutamate synthase | 0.0016 | 0.0214 | 0.0214 |
Trichomonas vaginalis | disulfide oxidoreductase, putative | 0.0016 | 0.0214 | 0.0502 |
Echinococcus multilocularis | cpg binding protein | 0.0031 | 0.0485 | 0.0578 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0016 | 0.0214 | 0.0502 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0061 | 0.1017 | 0.1057 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0061 | 0.1017 | 1 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0061 | 0.1017 | 0.1057 |
Toxoplasma gondii | thioredoxin reductase | 0.0177 | 0.3077 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0273 | 0.0677 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.002 | 0.0273 | 0.0078 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0196 | 0.3424 | 1 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0061 | 0.1017 | 0.1042 |
Mycobacterium ulcerans | hypothetical protein | 0.0051 | 0.0832 | 0.7694 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0061 | 0.1017 | 0.1057 |
Schistosoma mansoni | glutamate synthase | 0.0016 | 0.0214 | 0.0214 |
Trichomonas vaginalis | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0214 | 0.0502 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0061 | 0.1017 | 1 |
Schistosoma mansoni | kinase | 0.01 | 0.1703 | 0.1703 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 0.1656 | 0.477 |
Leishmania major | hypothetical protein, conserved | 0.0442 | 0.7806 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0196 | 0.3424 | 1 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0061 | 0.1017 | 0.1293 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0449 | 0.792 | 1 |
Trichomonas vaginalis | glutamate synthase, putative | 0.0016 | 0.0214 | 0.0502 |
Schistosoma mansoni | disulfide oxidoreductase | 0.0016 | 0.0214 | 0.0214 |
Trypanosoma brucei | trypanothione reductase | 0.0177 | 0.3077 | 0.3772 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0061 | 0.1017 | 0.2788 |
Schistosoma mansoni | glutamate synthase | 0.0016 | 0.0214 | 0.0214 |
Brugia malayi | NADPH:adrenodoxin oxidoreductase, mitochondrial precursor | 0.0016 | 0.0214 | 0.0383 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0061 | 0.1017 | 0.2878 |
Leishmania major | trypanothione reductase | 0.0177 | 0.3077 | 0.3772 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.002 | 0.0273 | 0.0078 |
Echinococcus granulosus | NADPH:adrenodoxin oxidoreductase | 0.0016 | 0.0214 | 0.0213 |
Leishmania major | 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative | 0.0051 | 0.0832 | 0.0814 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0404 | 0.7118 | 0.8958 |
Trichomonas vaginalis | disulfide oxidoreductase, putative | 0.0016 | 0.0214 | 0.0502 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0404 | 0.7118 | 0.8958 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0061 | 0.1017 | 1 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0061 | 0.1017 | 0.2803 |
Trichomonas vaginalis | disulfide oxidoreductase, putative | 0.0016 | 0.0214 | 0.0502 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0196 | 0.3424 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0196 | 0.3424 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0177 | 0.3077 | 0.8962 |
Echinococcus multilocularis | apoptosis inducing factor 1 mitochondrial | 0.0016 | 0.0214 | 0.0213 |
Plasmodium falciparum | thioredoxin reductase | 0.0177 | 0.3077 | 1 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.003 | 0.0455 | 0.11 |
Mycobacterium ulcerans | citrate (pro-3S)-lyase subunit beta | 0.0051 | 0.0832 | 0.7694 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.0455 | 0.0455 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0061 | 0.1017 | 0.1057 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0196 | 0.3424 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0214 | 0.0214 |
Toxoplasma gondii | exonuclease III APE | 0.002 | 0.0273 | 0.0206 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0404 | 0.7118 | 0.8958 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0061 | 0.1017 | 0.2803 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0061 | 0.1017 | 0.2803 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0178 | 0.3096 | 0.4091 |
Schistosoma mansoni | hypothetical protein | 0.0424 | 0.7488 | 0.7488 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0061 | 0.1017 | 0.1057 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0088 | 0.0044 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0061 | 0.1017 | 0.1057 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0061 | 0.1017 | 0.2803 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0196 | 0.3424 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0088 | 0.0044 |
Echinococcus granulosus | pyridine nucleotide disulfide oxidoreductase | 0.0016 | 0.0214 | 0.0213 |
Mycobacterium tuberculosis | Conserved protein | 0.0051 | 0.0832 | 0.0801 |
Schistosoma mansoni | cpg binding protein | 0.0031 | 0.0485 | 0.0485 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0016 | 0.0214 | 0.0213 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0196 | 0.3424 | 0.4228 |
Mycobacterium tuberculosis | Probable citrate (pro-3S)-lyase (beta subunit) CitE (citrase) (citratase) (citritase) (citridesmolase) (citrase aldolase) | 0.0051 | 0.0832 | 0.0801 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase family protein | 0.0016 | 0.0214 | 0.0383 |
Trichomonas vaginalis | dihydropyrimidine dehydrogenase, putative | 0.0016 | 0.0214 | 0.0502 |
Echinococcus granulosus | cpg binding protein | 0.0031 | 0.0485 | 0.0578 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0.0273 | 0.0735 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.002 | 0.0273 | 0.0735 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.002 | 0.0273 | 0.0184 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0061 | 0.1017 | 0.1057 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0061 | 0.1017 | 1 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0061 | 0.1017 | 0.1293 |
Echinococcus granulosus | glutamate synthase | 0.0016 | 0.0214 | 0.0213 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0178 | 0.3096 | 0.4091 |
Echinococcus multilocularis | glutamate synthase | 0.0016 | 0.0214 | 0.0213 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.002 | 0.0273 | 0.0292 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0196 | 0.3424 | 1 |
Mycobacterium ulcerans | citrate (pro-3S)-lyase subunit beta | 0.0051 | 0.0832 | 0.7694 |
Brugia malayi | CXXC zinc finger family protein | 0.003 | 0.0455 | 0.1105 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0196 | 0.3424 | 1 |
Onchocerca volvulus | 0.003 | 0.0455 | 0.0751 | |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0273 | 0.0273 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0007 | 0.0056 | 0.0056 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0177 | 0.3077 | 0.3716 |
Mycobacterium ulcerans | citrate lyase beta subunit, CitE_2 | 0.0051 | 0.0832 | 0.7694 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0045 | 0.0727 | 0.1919 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0273 | 0.0206 |
Schistosoma mansoni | cpg binding protein | 0.0031 | 0.0485 | 0.0485 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0273 | 0.0677 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0449 | 0.792 | 1 |
Trypanosoma brucei | polo-like protein kinase | 0.0196 | 0.3424 | 0.4228 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0196 | 0.3424 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0196 | 0.3424 | 0.4228 |
Giardia lamblia | Kinase, PLK | 0.0196 | 0.3424 | 1 |
Echinococcus multilocularis | pyridine nucleotide disulfide oxidoreductase | 0.0016 | 0.0214 | 0.0213 |
Echinococcus granulosus | dnaJ subfamily B | 0.0424 | 0.7488 | 1 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0196 | 0.3424 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0061 | 0.1017 | 1 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0016 | 0.0214 | 0.0213 |
Trypanosoma cruzi | 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative | 0.0051 | 0.0832 | 0.0814 |
Schistosoma mansoni | sulfide quinone reductase | 0.0016 | 0.0214 | 0.0214 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0404 | 0.7118 | 0.8958 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 0.1656 | 0.477 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0177 | 0.3077 | 0.8962 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0273 | 0.0273 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0442 | 0.7806 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0061 | 0.1017 | 0.1057 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0061 | 0.1017 | 0.1057 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0045 | 0.0727 | 0.1919 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0061 | 0.1017 | 0.1057 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0056 | 0.093 | 0.2501 |
Trichomonas vaginalis | disulfide oxidoreductase, putative | 0.0016 | 0.0214 | 0.0502 |
Echinococcus multilocularis | sulfide:quinone oxidoreductase | 0.0016 | 0.0214 | 0.0213 |
Echinococcus granulosus | sulfide:quinone oxidoreductase | 0.0016 | 0.0214 | 0.0213 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0196 | 0.3424 | 1 |
Echinococcus granulosus | citrate lyase subunit beta protein | 0.0051 | 0.0832 | 0.1044 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0404 | 0.7118 | 0.8958 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase family protein | 0.0016 | 0.0214 | 0.0383 |
Brugia malayi | glutathione reductase | 0.0177 | 0.3077 | 0.8962 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.002 | 0.0273 | 0.0554 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0196 | 0.3424 | 0.3424 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0442 | 0.7806 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0404 | 0.7118 | 0.8958 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0196 | 0.3424 | 0.4532 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0061 | 0.1017 | 0.1057 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0061 | 0.1017 | 0.1057 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0061 | 0.1017 | 0.1057 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0061 | 0.1017 | 0.1017 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0061 | 0.1017 | 1 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.002 | 0.0273 | 0.0077 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0273 | 0.0078 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0273 | 0.0078 |
Echinococcus multilocularis | NADPH:adrenodoxin oxidoreductase | 0.0016 | 0.0214 | 0.0213 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.002 | 0.0273 | 0.0735 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0196 | 0.3424 | 0.4228 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0177 | 0.3077 | 1 |
Trichomonas vaginalis | disulfide oxidoreductase, putative | 0.0016 | 0.0214 | 0.0502 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0214 | 0.0377 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0404 | 0.7118 | 0.8958 |
Loa Loa (eye worm) | programmed cell death 8 | 0.0016 | 0.0214 | 0.0377 |
Trichomonas vaginalis | glutamate synthase, putative | 0.0016 | 0.0214 | 0.0502 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0063 | 0.105 | 0.105 |
Trypanosoma cruzi | 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative | 0.0051 | 0.0832 | 0.0814 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0061 | 0.1017 | 0.2501 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0016 | 0.0214 | 0.0502 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0449 | 0.792 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.002 | 0.0273 | 0.0184 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0061 | 0.1017 | 0.2878 |
Trichomonas vaginalis | disulfide oxidoreductase, putative | 0.0016 | 0.0214 | 0.0502 |
Plasmodium falciparum | thioredoxin reductase | 0.0061 | 0.1017 | 0.2803 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0016 | 0.0214 | 0.0213 |
Echinococcus granulosus | apoptosis inducing factor 1 mitochondrial | 0.0016 | 0.0214 | 0.0213 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.